Growth Hormone Deficiency (GHD)
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Growth Hormone Deficiency (GHD)

View Main Condition: Short Stature (Growth Disorders)

Who are the top Growth Hormone Deficiency (GHD) Local Doctors?
Elite in Growth Hormone Deficiency (GHD)
Pediatric Endocrinology | Pediatrics | Endocrinology
Elite in Growth Hormone Deficiency (GHD)
Pediatric Endocrinology | Pediatrics | Endocrinology
Referral required

M Health Fairview Pediatric Specialty Clinic - Journey

2450 Riverside Ave, Floor 9, 
Minneapolis, MN 
Languages Spoken:
English
Offers Telehealth

Bradley Miller is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Minneapolis, MN. Dr. Miller is rated as an Elite provider by MediFind in the treatment of Growth Hormone Deficiency (GHD). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency, Hypopituitarism, Short Stature (Growth Disorders), and Hormone Replacement Therapy (HRT). Dr. Miller is board certified in American Board Of Pediatrics American Board Of Pediatrics - Pediatric Endocrinology.

Elite in Growth Hormone Deficiency (GHD)
Endocrinology
Elite in Growth Hormone Deficiency (GHD)
Endocrinology
Referral required

Barrow Neuro-Endocrine Clinic

240 W Thomas Rd, Suite 404, 
Phoenix, AZ 
Languages Spoken:
English, Cantonese, Malay, Mandarin
Accepting New Patients
Offers Telehealth

Kevin Yuen is an Endocrinologist practicing medicine in Phoenix, Arizona. Dr. Yuen is rated as an Elite provider by MediFind in the treatment of Growth Hormone Deficiency (GHD). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Growth Hormone Deficiency (GHD), Hypopituitarism, Sheehan Syndrome, Hormone Replacement Therapy (HRT), and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Yuen is board certified in Internal Medicine (Sub: Endocrinology, Diabetes & Met and Internal Medicine. Dr. Yuen is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Growth Hormone Deficiency (GHD)
Pediatrics | Pediatric Endocrinology
Elite in Growth Hormone Deficiency (GHD)
Pediatrics | Pediatric Endocrinology
Referral may be required

Pediatric Diabetes And Endocrinology-Morristown

55 Madison Avenue, Floor 2, 
Morristown, NJ 
Languages Spoken:
English
Accepting New Patients

Lawrence Silverman is a Pediatrics specialist and a Pediatric Endocrinologist practicing medicine in Morristown, New Jersey. Dr. Silverman is rated as an Elite provider by MediFind in the treatment of Growth Hormone Deficiency (GHD). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Precocious Puberty, Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), and Short Stature (Growth Disorders). Dr. Silverman is board certified in American Board Of Pediatrics. Dr. Silverman is currently accepting new patients.

What are the latest Growth Hormone Deficiency (GHD) Clinical Trials?
A Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children With Growth Hormone Deficiency in the First Year of Treatment

Summary: A prospective, randomized, open-label single-blinded study of 50 subjects with growth hormone deficiency, ages 5 to 15 years in which 25 subjects will initiate rhGH therapy at 0.3mg/kg/week and the remaining 25 subjects will initiate their rhGH treatment at 0.2 mg/kg/week for the first 12 months of treatment. Safety parameters, height velocity, and adult height prediction by bone age determination...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)

Summary: The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD) in naive to treatment children and validate the LUM-201 predictive enrichment marker (LUM-201 PEM) strategy to select subjects likely to respond to therapy with daily oral LUM-201.

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center